Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
43.96
+1.83 (4.34%)
At close: Aug 22, 2025, 4:00 PM
44.00
+0.04 (0.09%)
After-hours: Aug 22, 2025, 6:06 PM EDT

Bright Minds Biosciences Statistics

Total Valuation

DRUG has a market cap or net worth of $299.53 million. The enterprise value is $262.53 million.

Market Cap299.53M
Enterprise Value 262.53M

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date Aug 11, 2025
Ex-Dividend Date n/a

Share Statistics

DRUG has 7.08 million shares outstanding. The number of shares has increased by 49.67% in one year.

Current Share Class 7.08M
Shares Outstanding 7.08M
Shares Change (YoY) +49.67%
Shares Change (QoQ) +0.65%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 3.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.88
P/TBV Ratio 7.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 86.56, with a Debt / Equity ratio of 0.00.

Current Ratio 86.56
Quick Ratio 85.39
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -962.44

Financial Efficiency

Return on equity (ROE) is -30.79% and return on invested capital (ROIC) is -18.53%.

Return on Equity (ROE) -30.79%
Return on Assets (ROA) -18.31%
Return on Invested Capital (ROIC) -18.53%
Return on Capital Employed (ROCE) -16.59%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +4,167.96% in the last 52 weeks. The beta is 0.17, so DRUG's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change +4,167.96%
50-Day Moving Average 31.69
200-Day Moving Average 34.72
Relative Strength Index (RSI) 69.20
Average Volume (20 Days) 53,025

Short Selling Information

The latest short interest is 203,749, so 2.88% of the outstanding shares have been sold short.

Short Interest 203,749
Short Previous Month 169,044
Short % of Shares Out 2.88%
Short % of Float 6.78%
Short Ratio (days to cover) 5.21

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.31M
Pretax Income -3.82M
Net Income -6.54M
EBITDA n/a
EBIT -6.31M
Earnings Per Share (EPS) -$1.06
Full Income Statement

Balance Sheet

The company has $37.68 million in cash and $103,405 in debt, giving a net cash position of $37.57 million or $5.30 per share.

Cash & Cash Equivalents 37.68M
Total Debt 103,405
Net Cash 37.57M
Net Cash Per Share $5.30
Equity (Book Value) 38.00M
Book Value Per Share 5.36
Working Capital 37.95M
Full Balance Sheet

Cash Flow

Operating Cash Flow -5.78M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DRUG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.67%
Shareholder Yield -49.67%
Earnings Yield -2.18%
FCF Yield n/a

Analyst Forecast

The average price target for DRUG is $83.60, which is 90.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target $83.60
Price Target Difference 90.17%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 14, 2023. It was a reverse split with a ratio of 1:5.

Last Split Date Jul 14, 2023
Split Type Reverse
Split Ratio 1:5

Scores

Altman Z-Score n/a
Piotroski F-Score 2